Thank you for your patience while we transitioned to our upgraded systems. We continue to work through the backlog of orders, demographic changes, and other requests created during the downtime. Our priority is to resolve the backlog as quickly as possible. We appreciate your understanding and continued support.
Please log in to determine if you are eligible to purchase PT Programs.
SARS-COV-2 SEROLOGY - COVS
COVS
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte
Challenges per Shipment
Number of Shipments
SARS-CoV-2 antibodies (total, IgG, IgM, IgA)
3
Two shipments per year
For multiple instrument reporting options, see the Quality Cross Check program, COVSQ.
Program Information
Three 0.5‐mL serum specimens
Appropriate for assays that detect antibodies to nucleocapsid, spike, combined antigen (nucleocapsid and spike), and the receptor binding domain of the spike protein